Abstract:Background: Empirical data in proton therapy indicate that relative biological effectiveness (RBE) is not constant, and it is directly related to the linear energy transfer (LET). The experimental assessment of LET with high resolution would be a powerful tool for minimizing the LET hot spots in intensity-modulated proton therapy, RBE- or LET-guided evaluation and optimization to achieve biologically optimized proton plans, verifying the theoretical predictions of variable proton RBE models, and so on. This could impact clinical outcomes by reducing toxicities in organs at risk. Purpose: The present work shows the first 2D LET maps obtained at a proton therapy facility using the double scattering delivery mode in clinical conditions by means of new silicon 3D-cylindrical microdetectors. Methods: The device consists of a matrix of 121 independent silicon-based detectors that have 3D-cylindrical electrodes of 25-µm diameter and 20-µm depth, resulting each one of them in a well-defined micrometric radiation sensitive volume etched inside the silicon. They have been specifically designed for a hadron therapy, improving the performance of current silicon-based microdosimeters. Microdosimetry spectra were obtained at different positions of the Bragg curve by using a water-equivalent phantom along an 89-MeV pristine proton beam generated in the Y1 proton passive scattering beamline of the Orsay Proton Therapy Centre (Institut Curie, France). Results: Microdosimetry 2D-maps showing the variation of the lineal energy with depth in the three dimensions were obtained in situ during irradiation at clinical fluence rates (∼108 s-1 cm-2 ) for the first time with a spatial resolution of 200 µm, the highest achieved in the transverse plane so far. The experimental results were cross-checked with Monte Carlo simulations and a good agreement between the spectra shapes was found. The experimental frequency-mean lineal energy values in silicon were 1.858 ± 0.019 keV µm-1 at the entrance, 2.61 ± 0.03 keV µm-1 at the proximal distance, 4.97 ± 0.05 keV µm-1 close to the Bragg peak, and 8.6 ± 0.1 keV µm-1 at the distal edge. They are in good agreement with the expected trends in the literature in clinical proton beams. Conclusions: We present the first 2D microdosimetry maps obtained in situ during irradiation at clinical fluence rates in proton therapy. Our results show that the arrays of 3D-cylindrical microdetectors are a reliable microdosimeter to evaluate LET maps not only in the longitudinal axis of the beam, but also in the transverse plane allowing for LET characterization in three dimensions. This work is a proof of principle showing the capacity of our system to deliver LET 2D maps. This kind of experimental data is needed to validate variable proton RBE models and to optimize LET-guided plans.

Alanine Dosimeters for LET Measurement in Proton Radiotherapy

Alanine/EPR dosimetry for mailed intercomparison at ocular proton therapy facilities-preliminary results for three centres for irradaitions at CCB IFJ PAN eyeline

Single proton LET characterization with the Timepix detector and artificial intelligence for advanced proton therapy treatment planning

First experimental measurements of 2D microdosimetry maps in proton therapy

Assessment of fluence- and dose-averaged linear energy transfer with passive luminescence detectors in clinical proton beams

Optically stimulated luminescence dosimeters for simultaneous measurement of point dose and dose-weighted LET in an adaptive proton therapy workflow

Dose determination using alanine detectors in a mixed neutron and gamma field for boron neutron capture therapy of liver malignancies

Towards precise LET measurements based on energy deposition of therapeutic ions in Timepix3 detectors

A Monte Carlo study of different LET definitions and calculation parameters for proton beam therapy

Real-time measurement of two-dimensional LET distributions of proton beams using scintillators

Linear Energy Transfer Measurements and Estimation of Relative Biological Effectiveness in Proton and Helium-Ion Beams Using Fluorescent Nuclear Track Detectors

Feasibility of the J-PET to monitor the range of therapeutic proton beams

The alanine detector in BNCT dosimetry: dose response in thermal and epithermal neutron fields

Challenges for the Implementation of Primary Standard Dosimetry in Proton Minibeam Radiation Therapy

Direct Response to Proton Beam Linear Energy Transfer (let) in A Novel Polymer Gel Dosimeter Formulation

Enabling Clinical Use of Linear Energy Transfer in Proton Therapy for Head and Neck Cancer -- A Review of Implications for Treatment Planning and Adverse Events Study

Feasibility of the J-PET to monitor range of therapeutic proton beams

Status of LET assessment with active and passive detectors in ion beams

LET-weighted doses effectively reduce biological variability in proton radiotherapy planning

Optically Stimulated Luminescent Response of the LiMgPO4 Silicone Foils to Protons and Its Dependence on Proton Energy

Particle tracking, recognition and LET evaluation of out-of-field proton therapy delivered to a phantom with implants